CD8+ T cell-mediated control of distant tumours following local photodynamic therapy is independent of CD4+ T cells and dependent on natural killer cells.

PubWeight™: 1.14‹?› | Rank: Top 10%

🔗 View Article (PMC 2359961)

Published in Br J Cancer on May 15, 2007

Authors

E Kabingu1, L Vaughan, B Owczarczak, K D Ramsey, S O Gollnick

Author Affiliations

1: Department of Cell Stress Biology, PDT Center, Roswell Park Cancer Center, Elm and Carlton Sts., Buffalo, NY 14263, USA.

Articles citing this

Photodynamic therapy of cancer: an update. CA Cancer J Clin (2011) 6.08

Enhanced systemic immune reactivity to a Basal cell carcinoma associated antigen following photodynamic therapy. Clin Cancer Res (2009) 1.80

Photodynamic therapy enhancement of antitumor immunity is regulated by neutrophils. Cancer Res (2007) 1.55

Stimulation of anti-tumor immunity by photodynamic therapy. Expert Rev Clin Immunol (2011) 1.11

Enhancement of anti-tumor immunity by photodynamic therapy. Immunol Res (2010) 1.07

Nanoparticle-mediated combination chemotherapy and photodynamic therapy overcomes tumor drug resistance. J Control Release (2009) 1.02

Photodynamic therapy enhancement of anti-tumor immunity. Photochem Photobiol Sci (2011) 1.00

Cooperativity of adaptive and innate immunity: implications for cancer therapy. Cancer Immunol Immunother (2011) 0.93

Immunomodulation by food: promising concept for mitigating allergic disease? Anal Bioanal Chem (2009) 0.93

Tumor cell survival pathways activated by photodynamic therapy: a molecular basis for pharmacological inhibition strategies. Cancer Metastasis Rev (2015) 0.89

Immune response after photodynamic therapy increases anti-cancer and anti-bacterial effects. World J Immunol (2014) 0.87

Immunogenic cell death: can it be exploited in PhotoDynamic Therapy for cancer? Biomed Res Int (2012) 0.87

Combination of photodynamic therapy and immunomodulation: current status and future trends. Med Res Rev (2008) 0.85

Boosting Tumor-Specific Immunity Using PDT. Cancers (Basel) (2016) 0.84

Photodynamic therapy induces an immune response against a bacterial pathogen. Expert Rev Clin Immunol (2012) 0.82

Development of photodynamic therapy regimens that control primary tumor growth and inhibit secondary disease. Cancer Immunol Immunother (2014) 0.82

Pheophorbide a-Mediated Photodynamic Therapy Triggers HLA Class I-Restricted Antigen Presentation in Human Hepatocellular Carcinoma. Transl Oncol (2010) 0.81

The effect of photodynamic therapy on tumor cell expression of major histocompatibility complex (MHC) class I and MHC class I-related molecules. Lasers Surg Med (2012) 0.80

IL-6 potentiates tumor resistance to photodynamic therapy (PDT). Lasers Surg Med (2011) 0.79

Targeted Therapy of Cancer Using Photodynamic Therapy in Combination with Multi-faceted Anti-Tumor Modalities. Pharmaceuticals (Basel) (2010) 0.79

Adaptive control of innate immunity. Immunol Lett (2010) 0.79

Inhibition of NF-κB in Tumor Cells Exacerbates Immune Cell Activation Following Photodynamic Therapy. Int J Mol Sci (2015) 0.78

Photodynamic therapy-mediated cancer vaccination enhances stem-like phenotype and immune escape, which can be blocked by thrombospondin-1 signaling through CD47 receptor protein. J Biol Chem (2015) 0.78

Preclinical evaluation of light-activatable, bispecific anti-human CD3 antibody conjugates as anti-ovarian cancer therapeutics. MAbs (2009) 0.77

Porphyrin-based cationic amphiphilic photosensitisers as potential anticancer, antimicrobial and immunosuppressive agents. Biophys Rev (2017) 0.75

Requirement of Innate Immunity in Tumor-Bearing Mice Cured by Adoptive Immunotherapy Using Tumor-Draining Lymph Nodes. J Immunol Res (2015) 0.75

Low dose of GRP78-targeting subtilase cytotoxin improves the efficacy of photodynamic therapy in vivo. Oncol Rep (2016) 0.75

Oncologic Photodynamic Therapy: Basic Principles, Current Clinical Status and Future Directions. Cancers (Basel) (2017) 0.75

Articles cited by this

Innate immune recognition. Annu Rev Immunol (2001) 26.65

Toll-like receptors: critical proteins linking innate and acquired immunity. Nat Immunol (2001) 18.80

Tolerance, danger, and the extended family. Annu Rev Immunol (1994) 14.94

The danger model: a renewed sense of self. Science (2002) 13.85

Photodynamic therapy. J Natl Cancer Inst (1998) 12.83

T-cell help for cytotoxic T lymphocytes is mediated by CD40-CD40L interactions. Nature (1998) 12.70

A conditioned dendritic cell can be a temporal bridge between a CD4+ T-helper and a T-killer cell. Nature (1998) 12.07

Help for cytotoxic-T-cell responses is mediated by CD40 signalling. Nature (1998) 11.08

Requirement for CD4 T cell help in generating functional CD8 T cell memory. Science (2003) 10.22

CD4+ T cells are required for secondary expansion and memory in CD8+ T lymphocytes. Nature (2003) 10.16

Defective CD8 T cell memory following acute infection without CD4 T cell help. Science (2003) 9.67

Regulatory T cells, tumour immunity and immunotherapy. Nat Rev Immunol (2006) 9.42

Molecular identification of a danger signal that alerts the immune system to dying cells. Nature (2003) 8.90

Toll-like receptors control activation of adaptive immune responses. Nat Immunol (2001) 7.54

CD4+ T cells are required for the maintenance, not programming, of memory CD8+ T cells after acute infection. Nat Immunol (2004) 6.80

The present and future role of photodynamic therapy in cancer treatment. Lancet Oncol (2004) 4.95

Regulation of T cell immunity by dendritic cells. Cell (2001) 4.38

Photodynamic therapy and anti-tumour immunity. Nat Rev Cancer (2006) 3.93

Danger signals: SOS to the immune system. Curr Opin Immunol (2001) 3.91

Compromised influenza virus-specific CD8(+)-T-cell memory in CD4(+)-T-cell-deficient mice. J Virol (2002) 3.21

An update on photodynamic therapy applications. J Clin Laser Med Surg (2002) 2.94

Cooperation between CD4+ and CD8+ T cells: when, where, and how. Annu Rev Immunol (2006) 2.71

Tumor destruction and kinetics of tumor cell death in two experimental mouse tumors following photodynamic therapy. Cancer Res (1985) 2.43

Natural killer cells activated by MHC class I(low) targets prime dendritic cells to induce protective CD8 T cell responses. Immunity (2003) 2.03

The photobiology of photodynamic therapy: cellular targets and mechanisms. Radiat Res (1998) 2.00

Regulation of dendritic cell function through Toll-like receptors. Curr Mol Med (2003) 1.85

Choice of oxygen-conserving treatment regimen determines the inflammatory response and outcome of photodynamic therapy of tumors. Cancer Res (2004) 1.80

Induction of tumor-specific T cell memory by NK cell-mediated tumor rejection. Nat Immunol (2001) 1.70

Selective long-term elimination of natural killer cells in vivo by an anti-interleukin 2 receptor beta chain monoclonal antibody in mice. J Exp Med (1993) 1.67

Fully functional memory CD8 T cells in the absence of CD4 T cells. J Immunol (2004) 1.59

Dendritic cells: On the move from bench to bedside. Nat Med (2001) 1.52

Role of cytokines in photodynamic therapy-induced local and systemic inflammation. Br J Cancer (2003) 1.52

Photodynamic therapy-induced cell surface expression and release of heat shock proteins: relevance for tumor response. Cancer Res (2005) 1.49

Altered expression of interleukin 6 and interleukin 10 as a result of photodynamic therapy in vivo. Cancer Res (1997) 1.42

DC-NK cell cross talk as a novel CD4+ T-cell-independent pathway for antitumor CTL induction. Blood (2005) 1.39

Activation of CD8 T cells by mycobacterial vaccination protects against pulmonary tuberculosis in the absence of CD4 T cells. J Immunol (2004) 1.33

Induction of CD70 on dendritic cells through CD40 or TLR stimulation contributes to the development of CD8+ T cell responses in the absence of CD4+ T cells. J Immunol (2005) 1.31

Activation of dendritic cells that cross-present tumor-derived antigen licenses CD8+ CTL to cause tumor eradication. J Immunol (2004) 1.29

NK cells help to induce CD8(+)-T-cell immunity against Toxoplasma gondii in the absence of CD4(+) T cells. Infect Immun (2005) 1.23

Photodynamic therapy-mediated immune response against subcutaneous mouse tumors. Cancer Res (1999) 1.19

Stress proteins and the immune response. Immunopharmacology (2000) 1.19

Photodynamic therapy and anti-tumor immunity. Lasers Surg Med (2006) 1.17

Cell subpopulations dispersed from solid tumours and separated by centrifugal elutriation. Br J Cancer (1981) 1.15

Mediators of peripheral blood neutrophilia induced by photodynamic therapy of solid tumors. Cancer Lett (2002) 1.15

Photodynamic therapy of orthotopic prostate cancer with benzoporphyrin derivative: local control and distant metastasis. Cancer Res (1998) 1.11

Local photodynamic therapy (PDT) of rat C6 glioma xenografts with Pd-bacteriopheophorbide leads to decreased metastases and increase of animal cure compared with surgery. Int J Cancer (2002) 1.10

Interleukin 3 enhances cytotoxic T lymphocyte development and class I major histocompatibility complex "re-presentation" of exogenous antigen by tumor-infiltrating antigen-presenting cells. Proc Natl Acad Sci U S A (1996) 1.04

Photodynamic therapy and the immune system in experimental oncology. Photochem Photobiol Sci (2002) 1.03

Urinary cytokines following photodynamic therapy for bladder cancer. A preliminary report. Urology (1990) 1.02

Role of interleukin 1 and granulocyte colony-stimulating factor in photofrin-based photodynamic therapy of rat rhabdomyosarcoma tumors. Cancer Res (1997) 0.98

Induction of systemic neutrophil response in mice by photodynamic therapy of solid tumors. Photochem Photobiol (2001) 0.97

Elevated serum cytokine levels in mesothelioma patients who have undergone pleurectomy or extrapleural pneumonectomy and adjuvant intraoperative photodynamic therapy. Photochem Photobiol (2003) 0.97

Acute phase response-associated systemic neutrophil mobilization in mice bearing tumors treated by photodynamic therapy. Int Immunopharmacol (2006) 0.94

CD40 cross-linking bypasses the absolute requirement for CD4 T cells during immunization with melanoma antigen gene-modified dendritic cells. Cancer Res (2001) 0.90

Role of the immune system in mediating the antitumor effect of benzophenothiazine photodynamic therapy. Photochem Photobiol (1999) 0.90

Effects of photodynamic therapy with hypericin in mice bearing highly invasive solid tumors. Oncol Res (2000) 0.84

In vivo tumor necrosis factor-alpha induction following chlorin e6-photodynamic therapy in Buffalo rats. Neoplasma (1997) 0.84

The effect of localized porphyrin photodynamic therapy on the induction of tumour metastasis. Br J Cancer (1987) 0.83

Immunological aspects of photodynamic therapy of liver tumors in a rat model for colorectal cancer. Photochem Photobiol (2003) 0.82

CD4+ T cell-independent maintenance and expansion of memory CD8+ T cells derived from in vitro dendritic cell activation. Int Immunol (2006) 0.78

Articles by these authors

Structure and variation of human alpha 1-antitrypsin. Nature (1982) 4.13

Preseason strength and flexibility imbalances associated with athletic injuries in female collegiate athletes. Am J Sports Med (1991) 2.94

Cartilage contains mixed fibrils of collagen types II, IX, and XI. J Cell Biol (1989) 2.68

Beginning readers' use of orthographic analogies in word reading. J Exp Child Psychol (1998) 1.98

Noninvasive positive pressure ventilation for patients with terminal respiratory failure: the ethical and economic costs of delaying the inevitable are too great. Am J Crit Care (1994) 1.70

Role of cytokines in photodynamic therapy-induced local and systemic inflammation. Br J Cancer (2003) 1.52

Versican is selectively expressed in embryonic tissues that act as barriers to neural crest cell migration and axon outgrowth. Development (1995) 1.49

Altered expression of interleukin 6 and interleukin 10 as a result of photodynamic therapy in vivo. Cancer Res (1997) 1.42

Murine B-cell stimulatory factor 1 (interleukin 4) increases expression of the Fc receptor for IgE on mouse B cells. Proc Natl Acad Sci U S A (1987) 1.40

Proteoglycan Lt from chicken embryo sternum identified as type IX collagen. J Biol Chem (1985) 1.38

Protein tyrosine phosphatase alpha (PTPalpha) and contactin form a novel neuronal receptor complex linked to the intracellular tyrosine kinase fyn. J Cell Biol (1999) 1.35

A major, six-armed glycoprotein from embryonic cartilage. EMBO J (1987) 1.31

J1/tenascin in substrate-bound and soluble form displays contrary effects on neurite outgrowth. J Cell Biol (1991) 1.27

Type IX collagen from sternal cartilage of chicken embryo contains covalently bound glycosaminoglycans. Proc Natl Acad Sci U S A (1985) 1.24

Neuronal cell adhesion molecule contactin/F11 binds to tenascin via its immunoglobulin-like domains. J Cell Biol (1992) 1.18

Chlamydia-related abortions in cattle from Graubunden, Switzerland. Vet Pathol (2006) 1.18

alpha 1-Antitrypsin microheterogeneity. Isolation and physiological significance of isoforms. Biochim Biophys Acta (1982) 1.10

Analysis of Qa-2 antigen expression by preimplantation mouse embryos: possible relationship to the preimplantation-embryo-development (Ped) gene product. Biol Reprod (1987) 1.09

Identification of the type IX collagen polypeptide chains. The alpha 2(IX) polypeptide carries the chondroitin sulfate chain(s). J Biol Chem (1986) 1.07

The glypiated neuronal cell adhesion molecule contactin/F11 complexes with src-family protein tyrosine kinase Fyn. Mol Cell Neurosci (1995) 1.03

Human alpha 1-antitrypsin: carbohydrate attachment and sequence homology. FEBS Lett (1981) 1.02

Isolation and sequence analysis of the glycosaminoglycan attachment site of type IX collagen. J Biol Chem (1988) 1.02

Photosensitization of murine tumor, vasculature and skin by 5-aminolevulinic acid-induced porphyrin. Photochem Photobiol (1995) 1.02

Management of follicular thyroid carcinoma should be individualised based on degree of capsular and vascular invasion. Eur J Surg Oncol (2010) 1.02

Molecular evidence for chlamydial infections in the eyes of sheep. Vet Microbiol (2008) 1.01

Functional inactivation of Dermatophagoides spp. (house dust mite) reactive human T-cell clones. Clin Exp Allergy (1991) 1.01

Food-induced "dose-dumping" from a once-a-day theophylline product as a cause of theophylline toxicity. Chest (1985) 0.99

Interferon-alpha induces the expression of the L-selectin homing receptor in human B lymphoid cells. J Cell Biol (1993) 0.98

Fluoridation of drinking water. BMJ (1993) 0.98

Tenascin Mr 220,000 isoform expression correlates with corneal cell migration. Development (1991) 0.94

Novel Chlamydiales associated with epitheliocystis in a leopard shark Triakis semifasciata. Dis Aquat Organ (2010) 0.93

Detection of mycobacteria and chlamydiae in granulomatous inflammation of reptiles: a retrospective study. Vet Pathol (2004) 0.93

Chlamydiales in guinea-pigs and their zoonotic potential. J Vet Med A Physiol Pathol Clin Med (2006) 0.92

Red foxes (Vulpes vulpes) in Ireland as hosts for parasites of potential zoonotic and veterinary significance. Vet Rec (2002) 0.91

Diagnostic investigation into the role of Chlamydiae in cases of increased rates of return to oestrus in pigs. Vet Rec (2004) 0.91

Tenascin-C binds heparin by its fibronectin type III domain five. J Biol Chem (1995) 0.91

The clinical course of treated and untreated Gaucher disease. A study of 45 patients. Blood Cells Mol Dis (1995) 0.90

Energy-dependent endocytosis in erythrocyte ghosts. IV. Effects of Ca2+, Na+ +K+, and 5'-adenylylimidodiphosphate. Biochim Biophys Acta (1975) 0.90

Intensively kept pigs pre-disposed to chlamydial associated conjunctivitis. J Vet Med A Physiol Pathol Clin Med (2007) 0.90

Pigmented villonodular synovitis of the hip presenting as a retroperitoneal mass. Skeletal Radiol (2001) 0.89

Carboxy terminal fragment of human alpha-1-antitrypsin from hydroxylamine cleavage: homology with antithrombin III. Biochem Biophys Res Commun (1979) 0.88

Contactin/F11 and tenascin-C co-expression in the chick retina correlates with formation of the synaptic plexiform layers. Curr Eye Res (1995) 0.87

Comparative studies of collagens in normal and keratoconus corneas. Exp Eye Res (1988) 0.86

Chlamydiae in free-ranging and captive frogs in Switzerland. Vet Pathol (2007) 0.85

IL-10 does not play a role in cutaneous Photofrin photodynamic therapy-induced suppression of the contact hypersensitivity response. Photochem Photobiol (2001) 0.85

Purification, crystallization and preliminary crystallographic studies of a two fibronectin type-III domain segment from chicken tenascin encompassing the heparin- and contactin-binding regions. Acta Crystallogr D Biol Crystallogr (1999) 0.84

Comparison of train-of-four and best clinical assessment during continuous paralysis. Am J Respir Crit Care Med (1997) 0.84

HNK-1 carbohydrate-mediated cell adhesion to laminin-1 is different from heparin-mediated and sulfatide-mediated cell adhesion. Eur J Biochem (1997) 0.83

NIDDM: basic research plus education. Lancet (1991) 0.83

Linkage of the preimplantation-embryo-development (Ped) gene to the mouse major histocompatibility complex (MHC). Biol Reprod (1987) 0.83

Activation of the IL-10 gene promoter following photodynamic therapy of murine keratinocytes. Photochem Photobiol (2001) 0.82

Comparison of the Immulite and RIA assay methods for measuring peripheral blood progesterone levels in Greyhound bitches. Theriogenology (2008) 0.81

Section of the pituitary stalk in the rhesus monkey. I. Endocrine studies. Neuroendocrinology (1980) 0.81

A highly sensitive method for the detection of cell surface antigens on preimplantation mouse embryos. J Immunol Methods (1984) 0.81

Differential regulation of TGF-beta 2 by hormones in rat uterus and mammary gland. J Reprod Immunol (1996) 0.81

Lipid-associated methylpheophorbide-a (hexyl-ether) as a photodynamic agent in tumor-bearing mice. Photochem Photobiol (1993) 0.80

Activation of multiple transcription factors and fos and jun gene family expression in cells exposed to a single electric pulse. Exp Cell Res (1995) 0.80

Effects of photodynamic treatment of platelets or endothelial cells in vitro on platelet aggregation. Photochem Photobiol (1992) 0.80

An abattoir survey of ovine reproductive tracts in Ireland. Theriogenology (1998) 0.80

Cation control of erythrocyte membrane shape: Ca++ reversal of discocyte to echinocyte transition caused by Mg++ and other cations. Biochem Biophys Res Commun (1976) 0.79

Role of transforming growth factor-beta1 in the suppressed allostimulatory function of AIDS patients. AIDS (1998) 0.79

Expression of H-2K major histocompatibility antigens on preimplantation mouse embryos. Biol Reprod (1993) 0.79

Endocytosis in erythrocytes and ghosts: occurrence at 0 degrees C after ATP preincubation. Arch Biochem Biophys (1979) 0.79

Immunization of prepubertal beef heifers against gonadotropin-releasing hormone: immune, estrus, ovarian, and growth responses. J Anim Sci (1995) 0.78

Repression of MHC class II gene transcription in trophoblast cells by novel single-stranded DNA binding proteins. Mol Reprod Dev (1997) 0.78

Binding of contactin/F11 to the fibronectin type III domains 5 and 6 of tenascin is inhibited by heparin. FEBS Lett (1996) 0.78

Synthesis and evaluation of chalcogenopyrylium dyes as potential sensitizers for the photodynamic therapy of cancer. J Med Chem (1999) 0.78

Breeding soundness evaluation of bulls by semen analysis, testicular fine needle aspiration cytology and trans-scrotal ultrasonography. Ir Vet J (2008) 0.77

Dynamical implications of Viral Tiling Theory. J Theor Biol (2008) 0.77

Intraosseous ganglion of the patella. Skeletal Radiol (1996) 0.77

A selenopyrylium photosensitizer for photodynamic therapy related in structure to the antitumor agent AA1 with potent in vivo activity and no long-term skin photosensitization. J Med Chem (2000) 0.76

The reliability of serum theophylline determinations from clinical laboratories. Am Rev Respir Dis (1980) 0.76

Immunohistochemical expression study of proapoptotic BH3-only protein bad in canine nonneoplastic tissues and canine lymphomas. Vet Pathol (2013) 0.76

Distribution pattern of tenascin-C in normal and neoplastic mesenchymal tissues. Int J Cancer (1997) 0.76

Cytokine production by human soft tissue sarcomas: implications for immunosuppression within the tumour bed. Surg Oncol (1997) 0.76

Pantothenic acid content of human milk. Am J Clin Nutr (1981) 0.76

Clear-cell chondrosarcoma with elevated alkaline phosphatase, mistaken for osteosarcoma on biopsy. Skeletal Radiol (1996) 0.76

TGF-beta 2 gene and protein expression in maternal and fetal tissues at various stages of murine development. J Reprod Immunol (1993) 0.76

The diagnosis of freemartinism in cattle using sex-specific DNA sequences. Res Vet Sci (1999) 0.76

Water-soluble, core-modified porphyrins as novel, longer-wavelength-absorbing sensitizers for photodynamic therapy. J Med Chem (2000) 0.75

Uterine prolapse in a cat. Vet Rec (1993) 0.75

Influence of gender on theophylline dosage requirements in children with chronic asthma. Drug Intell Clin Pharm (1981) 0.75

Hidradenitis suppurativa of unusual severity. Ann Plast Surg (1983) 0.75

Nursing Mirror community forum. 9. Occupational health nursing: clearing confusion. Nurs Mirror (1983) 0.75

Physician consensus on preventability and predictability of readmissions based on standard case scenarios. Neth J Med (2016) 0.75

Dose dependency for absorption and elimination rates of theophylline. Implications for studies of bioavailability. Pharmacotherapy (1984) 0.75

Evaluation of dialyzers used in shortened dialysis. ASAIO Trans (1990) 0.75

Synthesis of H-2 antigens by preimplantation mouse embryos. Biol Reprod (1985) 0.75

Effect of estrogen on thyrotropin-releasing hormone-induced release of prolactin in intact, ovariectomized, and stalk-sectioned female rhesus monkeys. Endocrinology (1980) 0.75

Managing admissions. Bed spreads. Health Serv J (1997) 0.75

Nonenzymatic glucosylation of proteins: a new and rapid solution for in vitro investigation. FEBS Lett (1984) 0.75